New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
Medical Xpress
JULY 1, 2025
Researchers from the Wellcome Sanger Institute, the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust (CUH) and their collaborators analyzed blood cell genomes from 23 patients of all ages who had been treated with a range of chemotherapies. Whereas other drugs in the same class, such as oxaliplatin, did not.
101 
Let's personalize your content